In brief
- A functional MRI experiment with 37 healthy volunteers shows that ketamine’s analgesic effect and its dissociative effect leave separate brain signatures.
- Pain intensity was associated with activity in regions such as the anterior insula, while the intensity of dissociation was linked to reduced connectivity in the default mode network.
- Pain and dissociation indices showed no statistically significant association; this does not establish causal independence.
An Israeli team has put a widely held belief about ketamine to the test: whether analgesia and dissociation show the same brain associations. The study was published July 20, 2026 in Neuropsychopharmacology and describes distinct correlates. It does not establish independent causal pathways or that dissociation is unnecessary for every therapeutic benefit.
A design intended to separate two effects that usually go together
The paper by Noam Goldway and colleagues enrolled 37 healthy people (21 women), of whom 33 completed the procedure. It used a single-blind within-person fixed-order design: saline placebo always preceded ketamine, rather than randomized order. IV ketamine was a 0.4 mg/kg bolus over ten minutes followed by 0.4 mg/kg/h, with calibrated thermal stimulation on the right leg and CADSS dissociation assessment. Analysis sizes vary with available data.
Distinct correlates and nonsignificant associations
Analgesia and dissociation occurred relative to placebo. Pain was associated with regional activity and a multivoxel pattern; greater dissociation was associated with reduced default-mode connectivity. Cross-domain pain/dissociation associations were nonsignificant (ρ −0.24 to 0.32; all p>0.09). Failure to detect significance does not establish an exactly zero correlation or causal independence. That network’s connectivity is not an exclusive dissociation marker.
What this implies
The study generates hypotheses about analgesia and subjective-experience correlates, but does not show that a new molecule retains efficacy without dissociation. Fixed order confounds treatment with visit and cannot exclude habituation or expectancy; BOLD is indirect and may depend on vascular changes. This was brief thermal pain in healthy people, not clinical efficacy in chronic pain. As related reading, we covered an extended-release oral formulation that reduced dissociation; that link does not establish preserved efficacy: its depression trial missed significance on the primary endpoint. For general context on harm reduction guidelines, please consult our guides.
Source
- Goldway N, Jalon I, Agbaria Y, et al. “Ketamine-induced analgesia and dissociation show distinct behavioral and neural correlates.” Neuropsychopharmacology, July 20, 2026.
Educational content written from a harm reduction perspective and with respect for individual freedom. It is not a substitute for advice from a healthcare professional and is not intended to encourage or condemn any drug use.
